PHI with Dandy-Walker anomaly
How does this condition affect your private health insurance?
Dandy-Walker malformation is a congenital brain anomaly primarily affecting the cerebellum and the fourth ventricle. Characterized by an enlarged fourth ventricle, partial or complete absence of the cerebellar vermis, and often a cyst near the base of the skull, it typically presents with varying degrees of hydrocephalus. Symptoms, which can emerge in infancy or childhood, include developmental delays, poor muscle coordination, motor dysfunction, and increased head circumference. The severity and presentation are highly variable, ranging from mild to severe neurological impairment, impacting cognitive function, motor skills, and sometimes leading to seizures or other cranial nerve dysfunctions.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Manifests from birth or early infancy; initial symptoms and diagnosis represent the onset of a chronic condition rather than a temporary illness phase.
Duration of Illness (Lifetime)
Lifelong chronic condition requiring ongoing management and support.
Cost of Treatment (Initial)
High; includes diagnostic imaging, neurosurgical consultation, potential shunt placement for hydrocephalus, and initial developmental therapies.
Cost of Treatment (Lifetime)
Very high; involves lifelong specialist medical care, rehabilitative therapies (physical, occupational, speech), educational support, and potential further surgical interventions.
Mortality Rate
Moderate, especially in severe cases with significant hydrocephalus or associated anomalies, but improved with modern neurosurgical management.
Risk of Secondary Damages
High; common sequelae include significant developmental delays, intellectual disability, motor impairment (ataxia), epilepsy, and visual or hearing deficits.
Probability of Full Recovery
Very low; as a structural brain malformation, complete recovery is not possible, but symptoms can be managed and improved with early intervention.
Underlying Disease Risk
Moderate to high; often associated with genetic syndromes (e.g., trisomies, specific gene mutations), other CNS malformations, or systemic anomalies (e.g., cardiac, renal).